Latest Cynata Therapeutics (ASX:CYP) News

Page 2

Page 2 of 2

Cynata Advances with Positive Diabetic Foot Ulcer Trial and $10.5m Cash Buffer

Cynata Therapeutics reports encouraging Phase 1 results for its diabetic foot ulcer treatment CYP-006TK, alongside a strengthened balance sheet and ongoing clinical progress.

Ada Torres

30 Jan 2025